Doctors calls for more rational approach to drug pricing policy

The government needs to conduct drug pricing policy in more careful manner to guarantee the success of so-called positive list system.

In a recent symposium organized by the Korean Medical Association, all panelists from seven medical associations said that the controversial research report released by the Ministry of Health and Welfare Affairs lacks a rationale to evaluate the pharmacoecnom...